Making Medicines affordable.

News Room

Press Releases

Releases 2012Releases 2011Releases 2010Releases 2009 Releases 2008 Releases 2007 Releases 2006 Releases 2005 Releases 2004

Media Kit

Press Releases

2012

PRESS RELEASE | Rome - Brussels, 27 Janaury 2012

The European Generic medicines Association (EGA) together with the Italian association for generic medicines (ASSOGENERICI) welcome the European Commission’s formal call yesterday on Italy to comply with EU rules on the marketing authorisation of generic medicines. The European Commission infringement procedure started last year, following the EGA and ASSOGENERICI’s official complaint to the European Commission against the delays in granting market authorisation of generic medicines caused by incorrect linkage to intellectual property rights. More...

The EGA

“In an era when increasing demands are being made on Europe’s healthcare services, generic medicines provide a major benefit to society as they ensure patient access to quality, safe and effective medicines while reducing the cost of medicinal care.”

The EGA is the official representative body of the European generic and biosimilar pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans while stimulating competitiveness and innovation in the pharmaceutical sector.

The EGA represents over 1000 companies and their subsidiaries from greater Europe, and over 150,000 jobs. Generic medicines save €30 billion each year for health care systems and patients.

For further information: